Search
Brexpiprazole
go.drugbank.com/drugs/DB09128ApprovedInvestigationalIt also displays stronger antagonism at the 5-HT1A and 5-HT2A receptors.[A182186, A38385, A259661] Brexpiprazole was first approved by the FDA on July 10, 2015. … It has a high affinity for serotonin, dopamine and alpha (α)-adrenergic receptors.
Products: REXULTI (BREXPIPRAZOLE) TABLETS 1 MG, REXULTI (BREXPIPRAZOLE) TABLETS 2 MGHyaluronidase
go.drugbank.com/drugs/DB14740ApprovedInvestigational[A199026] Hyaluronidase has been used in surgical settings for at least the past 60 years to improve the diffusion of local anesthetics. … [A199026] Early research into hyaluronidase identified it as a "spreading factor" which allowed for increased permeability of the connective tissue.
Products: Wydase Injection Liq 150 Units/ml, Wydase Inj 150unit/mlMelphalan
go.drugbank.com/drugs/DB01042ApprovedInvestigational[L40928] It is also used for high-conditioning before hematopoietic stem cell transplant.[L47890] It is also used to treat uveal melanoma with unresectable hepatic metastases.[L47895] … [L40928] It was first synthesized in the early 1950s by substituting L-phenylalanine for the methyl group on nitrogen mustard.
Products: ALKERAN FOR INJECTION 50 mg/vial, Melphalan medac 50 mg Pulver und Lösungsmittel zur Herstellung einer Injektions-/InfusionslösungEvening primrose oil
go.drugbank.com/drugs/DB11358ApprovedNutraceuticalEvening primrose oil comes from the extraction from _Oenothera biennis_ seeds and it is commonly used as an alternative source for omega-6 essential fatty acids. … In its composition it presents some fatty acids such as [DB00132] and [DB13854].
Mixtures: OGAMIX(Evening primrose oil 500 mg, Lecithin oil 500 mg, Fish oil 125 mgand Vitamin E 10 mg Soft Gelatin Capsule), Hovid Omega-3 + 6Categories: Fatty Acids, Omega-6Ponatinib
go.drugbank.com/drugs/DB08901ApprovedInvestigationalPonatinib is a novel Bcr-Abl tyrosine kinase inhibitor that is especially effective against the T315I mutation for the treatment of chronic myeloid leukemia. FDA approved on December 14, 2012.
Products: Iclusig 30 mg Film Kaplı Tablet (30 adet), Iclusig 15 mg Film Kaplı Tablet (30 adet)Decitabine
go.drugbank.com/drugs/DB01262ApprovedInvestigational[A2263, A2264, A2265, A215317, L14962] Decitabine was developed by MGI Pharma/SuperGen Inc. and was approved by the FDA for the treatment of MDS on February 5, 2006. … It was first marketed under the name Dacogen®.[L14962] It is also available as an oral combination product together with the cytidine deaminase inhibitor [cedazuridine].
Products: DECITABINA 50 MG, AURODECINJET 50 MGChlorzoxazone
go.drugbank.com/drugs/DB00356ApprovedIt is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
Mixtures: MEPADOL TABLET, 20 ADET, MUSKAZON TABLET, 20 ADETProducts: PARAFLEX 250 MG TABLET, 20 ADET, PARAFLEX FORTE TABLET 500 MG, 20 ADETMagnesium salicylate
go.drugbank.com/drugs/DB01397ApprovedThough the recommended doseage is 1160 mg every six hours, per package directions of the Doan's OTC brand (580 mg magnesium salicylate tetrahydrate, equivalent to 934.4 mg anhydrous magnesium salicylate … It is available in several over-the-counter (OTC) formulations.
Mixtures: Vica-cetProducts: Back-ese M Tablets 325 mg, Medique at Home Back Pain ReliefMisoprostol
go.drugbank.com/drugs/DB00929ApprovedInvestigationalMisoprostol is a prostaglandin analog used to reduce the risk of NSAID related ulcers, manage miscarriages, prevent post partum hemorrhage, and also for first trimester abortions. The stimulation of prostaglandin receptors in the stomach...
Mixtures: ARTHROTEC 75 MG 10 TABLET, DIFEMIS 50 MG/0.2 MG TABLET, 20 ADETCategories: Prostaglandin E1 Analog, Prostaglandins E, SyntheticMefloquine
go.drugbank.com/drugs/DB00358ApprovedThe 2020 World Health Organization malaria report indicates a 60% decrease in the global malaria fatality rate between 2000 to 2019. … It was approved by the FDA in 1989, and was first marketed by Hoffman Laroche.
Mixtures: อาร์ทีซูเนทและเมฟลอควินไฮโดรคลอไรด์ 100/220 มก.Products: Lariam 250 mg Tabletten, MEFLOTAS TABLET 250 mg